{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T22:36:29Z","timestamp":1795041389884,"version":"4.10.2"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T00:00:00Z","timestamp":1649462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T00:00:00Z","timestamp":1649462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2016YFA0502500"],"award-info":[{"award-number":["2016YFA0502500"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2020YFE0201600"],"award-info":[{"award-number":["2020YFE0201600"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Proteome Sci"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The surveillance and therapy of early-stage cancer would be better for patients\u2019 prognosis. However, the extreme trace amount of tissue samples in different stages have limited in portraying the characterization of early-stage cancer. Therefore, we focused on and presented comprehensive proteomic and phosphoproproteomic profiling of the trace FFPE samples from early-stage gastrointestinal cancer, and then explored the potential biomarkers of early-stage gastrointestinal cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, a quantitative proteomic method with chromatography with mass spectrometry (LC-MS\/MS) was used to analyse the proteomic difference between the trace early-stage esophageal squamous cell carcinoma (EESCC) and early-stage duodenum adenocarcinoma cancer (EDAC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified ~\u20096000 proteins and\u2009&gt;\u200910,000 phosphosites in single trace FFPE samples. Comparative analysis disclosed the diverse proteomic features of tumor tissues compared with paired normal tissue of EESCC and EDAC, and revealed the difference of EESCC and EDAC was derived from their origin normal tissue. The distinct separation of EESCC and EDAC illustrated the functions of cell cycle (RB1 T373, EGFR T693) in EESCC, and the positive impacts of apoptosis, metabolic processes (MTOR and MTOR S1261) in EDAC. Furthermore, we deconvoluted the immune infiltration of early-stage gastrointestinal cancer, in which higher immune cell signatures were detected in EDAC, and showed the specific cytokines in EESCC and EDAC. We performed kinases-substates relationship analysis and elucidated the specific proteomic kinase characterization of EESCC and EDAC, and proposed the medicative effects and corresponding drugs for EESCC and EDAC at the clinic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We disclosed the specific immune characterization of the early-stage gastrointestinal cancer, and presented potential makers of EESCC (EGFR, PDGFRB, CDK4, WEE1) and EDAC (MTOR, MAP2K1, MAPK3). This study represents a major stepping stone towards investigating the carcinogenesis mechanism of gastrointestinal cancer, and providing a rich resource for medicative strategy in the clinic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s12953-022-00188-0","type":"journal-article","created":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T03:04:50Z","timestamp":1649473490000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Integrative proteomic characterization of trace FFPE samples in early-stage gastrointestinal cancer"],"prefix":"10.1186","volume":"20","author":[{"given":"Lingling","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,9]]},"reference":[{"issue":"6","key":"188_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"188_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, et al. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"issue":"23","key":"188_CR3","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1056\/NEJMra035010","volume":"349","author":"PC Enzinger","year":"2003","unstructured":"Enzinger PC, Mayer RJ. Medical progress - esophageal cancer. N Engl J Med. 2003;349(23):2241\u201352.","journal-title":"N Engl J Med"},{"issue":"5","key":"188_CR4","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1067\/mge.2001.118643","volume":"54","author":"H Yamamoto","year":"2001","unstructured":"Yamamoto H, et al. Successful en bloc resection of a large superficial gastric cancer by using sodium hyaluronate and electrocautery incision forceps. Gastrointest Endosc. 2001;54(5):629\u201332.","journal-title":"Gastrointest Endosc"},{"key":"188_CR5","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12957-015-0724-1","volume":"13","author":"WC Song","year":"2015","unstructured":"Song WC, Qiao XL, Gao XZ. A comparison of endoscopic submucosal dissection (ESD) and radical surgery for early gastric cancer: a retrospective study. World J Surg Oncol. 2015;13:309.","journal-title":"World J Surg Oncol"},{"issue":"5","key":"188_CR6","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1007\/s00464-016-5208-z","volume":"31","author":"D Jiang","year":"2017","unstructured":"Jiang D, et al. A retrospective study of endoscopic resection for 368 patients with early esophageal squamous cell carcinoma or precancerous lesions. Surg Endosc. 2017;31(5):2122\u201330.","journal-title":"Surg Endosc"},{"issue":"2","key":"188_CR7","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.gie.2013.08.002","volume":"79","author":"S Wani","year":"2014","unstructured":"Wani S, et al. Comparison of endoscopic therapies and surgical resection in patients with early esophageal cancer: a population-based study. Gastrointest Endosc. 2014;79(2):224\u2013232 e1.","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"188_CR8","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s12864-019-5639-8","volume":"20","author":"J Zhong","year":"2019","unstructured":"Zhong J, et al. Enhanced and controlled chromatin extraction from FFPE tissues and the application to ChIP-seq. BMC Genomics. 2019;20(1):249.","journal-title":"BMC Genomics"},{"issue":"11","key":"188_CR9","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1002\/1878-0261.12570","volume":"13","author":"Y Zhu","year":"2019","unstructured":"Zhu Y, et al. High-throughput proteomic analysis of FFPE tissue samples facilitates tumor stratification. Mol Oncol. 2019;13(11):2305\u201328.","journal-title":"Mol Oncol"},{"issue":"4","key":"188_CR10","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.cell.2019.03.030","volume":"177","author":"S Vasaikar","year":"2019","unstructured":"Vasaikar S, et al. Proteogenomic analysis of human Colon Cancer reveals new therapeutic opportunities. Cell. 2019;177(4):1035\u20131049 e19.","journal-title":"Cell"},{"issue":"1","key":"188_CR11","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/s41467-018-03121-2","volume":"9","author":"S Ge","year":"2018","unstructured":"Ge S, et al. A proteomic landscape of diffuse-type gastric cancer. Nat Commun. 2018;9(1):1012.","journal-title":"Nat Commun"},{"issue":"1","key":"188_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27\u201330.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"188_CR13","doi-asserted-by":"publisher","first-page":"R37","DOI":"10.1186\/gb-2013-14-4-r37","volume":"14","author":"P Casado","year":"2013","unstructured":"Casado P, et al. Phosphoproteomics data classify hematological cancer cell lines according to tumor type and sensitivity to kinase inhibitors. Genome Biol. 2013;14(4):R37.","journal-title":"Genome Biol"},{"issue":"6","key":"188_CR14","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/pmic.200300772","volume":"4","author":"PV Hornbeck","year":"2004","unstructured":"Hornbeck PV, et al. Phosphosite: a bioinformatics resource dedicated to physiological protein phosphorylation. Proteomics. 2004;4(6):1551\u201361.","journal-title":"Proteomics"},{"key":"188_CR15","doi-asserted-by":"publisher","first-page":"D261","DOI":"10.1093\/nar\/gkq1104","volume":"39","author":"H Dinkel","year":"2011","unstructured":"Dinkel H, et al. Phospho.ELM: a database of phosphorylation sites-update 2011. Nucleic Acids Res. 2011;39:D261\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"16","key":"188_CR16","doi-asserted-by":"publisher","first-page":"I14","DOI":"10.1093\/bioinformatics\/btn297","volume":"24","author":"CY Yang","year":"2008","unstructured":"Yang CY, et al. PhosphoPOINT: a comprehensive human kinase interactome and phospho-protein database. Bioinformatics. 2008;24(16):I14\u201320.","journal-title":"Bioinformatics"},{"issue":"11","key":"188_CR17","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/nbt1146","volume":"23","author":"D Schwartz","year":"2005","unstructured":"Schwartz D, Gygi SP. An iterative statistical approach to the identification of protein phosphorylation motifs from large-scale data sets. Nat Biotechnol. 2005;23(11):1391\u20138.","journal-title":"Nat Biotechnol"},{"issue":"268","key":"188_CR18","doi-asserted-by":"publisher","first-page":"rs6","DOI":"10.1126\/scisignal.2003573","volume":"6","author":"P Casado","year":"2013","unstructured":"Casado P, et al. Kinase-substrate enrichment analysis provides insights into the heterogeneity of signaling pathway activation in leukemia cells. Sci Signal. 2013;6(268):rs6.","journal-title":"Sci Signal"},{"issue":"D1","key":"188_CR19","doi-asserted-by":"publisher","first-page":"D512","DOI":"10.1093\/nar\/gku1267","volume":"43","author":"PV Hornbeck","year":"2015","unstructured":"Hornbeck PV, et al. PhosphoSitePlus, 2014: mutations, PTMs and recalibrations. Nucleic Acids Res. 2015;43(D1):D512\u201320.","journal-title":"Nucleic Acids Res"},{"issue":"7747","key":"188_CR20","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41586-019-0987-8","volume":"567","author":"Y Jiang","year":"2019","unstructured":"Jiang Y, et al. Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma. Nature. 2019;567(7747):257.","journal-title":"Nature"},{"issue":"7439","key":"188_CR21","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/nature11848","volume":"495","author":"B Schwanhausser","year":"2013","unstructured":"Schwanhausser B, et al. Global quantification of mammalian gene expression control (vol 473, pg 337, 2011). Nature. 2013;495(7439):126\u20137.","journal-title":"Nature"},{"issue":"7347","key":"188_CR22","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature10098","volume":"473","author":"B Schwanhausser","year":"2011","unstructured":"Schwanhausser B, et al. Global quantification of mammalian gene expression control. Nature. 2011;473(7347):337\u201342.","journal-title":"Nature"},{"issue":"1","key":"188_CR23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41467-018-07960-x","volume":"10","author":"X Ni","year":"2019","unstructured":"Ni X, et al. A region-resolved mucosa proteome of the human stomach. Nat Commun. 2019;10(1):39.","journal-title":"Nat Commun"},{"issue":"1","key":"188_CR24","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.cell.2020.05.043","volume":"182","author":"JY Xu","year":"2020","unstructured":"Xu JY, et al. Integrative proteomic characterization of human lung adenocarcinoma. Cell. 2020;182(1):245.","journal-title":"Cell"},{"issue":"3","key":"188_CR25","first-page":"265","volume":"20","author":"R Yazdian-Robati","year":"2017","unstructured":"Yazdian-Robati R, et al. Comparative proteome analysis of human esophageal cancer and adjacent normal tissues. Iranian J Basic Med Sci. 2017;20(3):265\u201371.","journal-title":"Iranian J Basic Med Sci"},{"issue":"6","key":"188_CR26","doi-asserted-by":"publisher","first-page":"510","DOI":"10.4161\/cbt.12.6.16833","volume":"12","author":"H Pawar","year":"2011","unstructured":"Pawar H, et al. Quantitative tissue proteomics of esophageal squamous cell carcinoma for novel biomarker discovery. Cancer Biol Ther. 2011;12(6):510\u201322.","journal-title":"Cancer Biol Ther"},{"issue":"9","key":"188_CR27","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1073\/pnas.091062498","volume":"98","author":"VG Tusher","year":"2001","unstructured":"Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A. 2001;98(9):5116\u201321.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7498","key":"188_CR28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nature13176","volume":"509","author":"YM Song","year":"2014","unstructured":"Song YM, et al. Identification of genomic alterations in oesophageal squamous cell cancer. Nature. 2014;509(7498):91.","journal-title":"Nature"},{"issue":"2","key":"188_CR29","doi-asserted-by":"publisher","first-page":"152","DOI":"10.4161\/cbt.5.2.2318","volume":"5","author":"MZ Guo","year":"2006","unstructured":"Guo MZ, et al. Gefitinib-sensitizing mutation in esophageal carcinoma cell line Kyse450. Cancer Biol Ther. 2006;5(2):152\u20135.","journal-title":"Cancer Biol Ther"},{"issue":"11","key":"188_CR30","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1001\/jamaoncol.2017.1051","volume":"3","author":"AB Schrock","year":"2017","unstructured":"Schrock AB, et al. Genomic profiling of small-bowel adenocarcinoma. Jama Oncol. 2017;3(11):1546\u201353.","journal-title":"Jama Oncol"},{"issue":"6","key":"188_CR31","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1172\/JCI67963","volume":"123","author":"MS Banck","year":"2013","unstructured":"Banck MS, et al. The genomic landscape of small intestine neuroendocrine tumors. J Clin Investig. 2013;123(6):2502\u20138.","journal-title":"J Clin Investig"},{"issue":"6","key":"188_CR32","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1053\/j.gastro.2010.01.058","volume":"138","author":"J Terzic","year":"2010","unstructured":"Terzic J, et al. Inflammation and Colon Cancer. Gastroenterology. 2010;138(6):2101\u2013U119.","journal-title":"Gastroenterology"},{"issue":"1","key":"188_CR33","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18(1):220.","journal-title":"Genome Biol"},{"issue":"10223","key":"188_CR34","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"CL Huang","year":"2020","unstructured":"Huang CL, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497\u2013506.","journal-title":"Lancet"},{"issue":"3","key":"188_CR35","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/nchembio.297","volume":"6","author":"O Fedorov","year":"2010","unstructured":"Fedorov O, Muller S, Knapp S. The (un)targeted cancer kinome. Nat Chem Biol. 2010;6(3):166\u20139.","journal-title":"Nat Chem Biol"},{"issue":"7","key":"188_CR36","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nchembio.1817","volume":"11","author":"JM Bradshaw","year":"2015","unstructured":"Bradshaw JM, et al. Prolonged and tunable residence time using reversible covalent kinase inhibitors. Nat Chem Biol. 2015;11(7):525.","journal-title":"Nat Chem Biol"},{"issue":"5","key":"188_CR37","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nrd.2018.21","volume":"17","author":"FM Ferguson","year":"2018","unstructured":"Ferguson FM, Gray NS. Kinase inhibitors: the road ahead. Nat Rev Drug Discov. 2018;17(5):353\u201377.","journal-title":"Nat Rev Drug Discov"},{"issue":"32","key":"188_CR38","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.1200\/JCO.2017.75.6155","volume":"35","author":"MP Goetz","year":"2017","unstructured":"Goetz MP, et al. MONARCH 3: Abemaciclib as initial therapy for advanced breast Cancer. J Clin Oncol. 2017;35(32):3638.","journal-title":"J Clin Oncol"},{"issue":"2","key":"188_CR39","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1203421","volume":"367","author":"KT Flaherty","year":"2012","unstructured":"Flaherty KT, et al. Improved survival with MEK inhibition in BRAF-mutated melanoma. N Engl J Med. 2012;367(2):107\u201314.","journal-title":"N Engl J Med"},{"issue":"10","key":"188_CR40","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1001\/jamapediatrics.2013.465","volume":"167","author":"JD Momper","year":"2013","unstructured":"Momper JD, et al. Adolescent dosing and labeling since the Food and Drug Administration amendments act of 2007. JAMA Pediatr. 2013;167(10):926\u201332.","journal-title":"JAMA Pediatr"},{"issue":"7","key":"188_CR41","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/nrm2203","volume":"8","author":"JA Ubersax","year":"2007","unstructured":"Ubersax JA, Ferrell JE. Mechanisms of specificity in protein phosphorylation. Nat Rev Mol Cell Biol. 2007;8(7):530\u201341.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10","key":"188_CR42","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1158\/1535-7163.MCT-16-0243","volume":"15","author":"TN Beck","year":"2016","unstructured":"Beck TN, et al. EGFR and RB1 as dual biomarkers in HPV-negative head and neck Cancer. Mol Cancer Ther. 2016;15(10):2486\u201397.","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"188_CR43","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1200\/JCO.18.01585","volume":"37","author":"N Marcoux","year":"2019","unstructured":"Marcoux N, et al. EGFR-mutant adenocarcinomas that transform to small-cell lung Cancer and other neuroendocrine carcinomas: clinical outcomes. J Clin Oncol. 2019;37(4):278.","journal-title":"J Clin Oncol"},{"issue":"12","key":"188_CR44","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/s41575-018-0054-1","volume":"15","author":"SM Man","year":"2018","unstructured":"Man SM. Inflammasomes in the gastrointestinal tract: infection, cancer and gut microbiota homeostasis. Nat Rev Gastroenterol Hepatol. 2018;15(12):721\u201337.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"188_CR45","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jbior.2018.02.001","volume":"68","author":"K Echizen","year":"2018","unstructured":"Echizen K, et al. The inflammatory microenvironment that promotes gastrointestinal cancer development and invasion. Adv Biol Regul. 2018;68:39\u201345.","journal-title":"Adv Biol Regul"},{"issue":"6","key":"188_CR46","first-page":"S1528","volume":"6","author":"AJJ Smits","year":"2011","unstructured":"Smits AJJ, et al. The frequency of Egfr and Kras mutations in non-small cell lung carcinomas in the Dutch population. J Thorac Oncol. 2011;6(6):S1528.","journal-title":"J Thorac Oncol"},{"issue":"4","key":"188_CR47","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/ni.3691","volume":"18","author":"AV Villarino","year":"2017","unstructured":"Villarino AV, Kanno Y, O'Shea JJ. Mechanisms and consequences of Jak-STAT signaling in the immune system. Nat Immunol. 2017;18(4):374\u201384.","journal-title":"Nat Immunol"},{"issue":"8","key":"188_CR48","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.ctrv.2013.05.001","volume":"39","author":"M Roengvoraphoj","year":"2013","unstructured":"Roengvoraphoj M, et al. Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non-small cell lung cancer: focus on epidermal growth factor receptor mutation testing and mutation-positive patients. Cancer Treat Rev. 2013;39(8):839\u201350.","journal-title":"Cancer Treat Rev"}],"container-title":["Proteome Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12953-022-00188-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12953-022-00188-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12953-022-00188-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T05:04:21Z","timestamp":1649480661000},"score":1,"resource":{"primary":{"URL":"https:\/\/proteomesci.biomedcentral.com\/articles\/10.1186\/s12953-022-00188-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,9]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["188"],"URL":"https:\/\/doi.org\/10.1186\/s12953-022-00188-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1084524\/v1","asserted-by":"object"}]},"ISSN":["1477-5956"],"issn-type":[{"value":"1477-5956","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,9]]},"assertion":[{"value":"16 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was carried out in compliance with the ethical standards of Helsinki Declaration II and approved by the Institution Review Board of Fudan University Zhongshan Hospital (B2019-200R).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}